Condition

Neoadjuvant Chemoimmunotherapy clinical trials and research

• 12Clinical trials
• 6Countries

Newest Neoadjuvant Chemoimmunotherapy clinical trials

All recruiting trials (12)

• Using CT scans to predict benefit from chemoimmunotherapy before lung cancer surgery

  This project will test whether CT scan features can predict how adults with resectable non-small cell lung cancer respond to chemoimmunotherapy given before surgery.

  Recruiting Samsung Medical Center · Seoul · NCT07559123

• Robotic-assisted sleeve lobectomy after neoadjuvant chemoimmunotherapy for stage IIB-III non-small cell lung cancer

  See how often robotic-assisted sleeve lobectomy after neoadjuvant chemoimmunotherapy succeeds and what makes the surgery harder for adults with stage IIB-III non-small cell lung cancer.

  Recruiting at 10 sites Shanghai Chest Hospital · Fuzhou, Fujian and 9 other locations · NCT07541521

• Tumor downstaging and robotic lung surgery after pre‑operative chemo‑immunotherapy for stage IIB–III NSCLC

  This project will see if tumor and lymph node shrinkage after pre‑surgery chemo‑immunotherapy leads to safer operations and quicker recoveries for people with stage IIB–III non‑small cell lung cancer who have robotic lung surgery.

  Recruiting at 10 sites Shanghai Chest Hospital · Fuzhou, Fujian and 9 other locations · NCT07528066

• Skin tattoo marks (and optional clips) to guide breast-conserving surgery before chemotherapy

  This study will test whether marking palpable tumor edges with sterile skin tattoos, with or without small radiopaque clips, before neoadjuvant chemotherapy helps surgeons perform breast-conserving surgery in adults with T2–T3 breast cancer.

  Recruiting All India Institute of Medical Sciences, Bhubaneswar · Bhubaneswar, Odisha · NCT07478900

• Neoadjuvant radiotherapy plus SOX chemotherapy with Iparomlimab and Tuvonralimab for resectable gastric and gastroesophageal junction adenocarcinoma

  This trial will test whether adding radiotherapy to pre-surgery SOX chemotherapy plus two immunotherapy drugs (Iparomlimab and Tuvonralimab) helps people with resectable, HER2‑negative gastric or gastroesophageal junction cancer.

  Recruiting Phase 2 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University · Chongqing, Other (Non U.s.) · NCT07165847

• Neoadjuvant chemo‑immunotherapy to make inoperable epithelioid pleural mesothelioma operable (NECIM)

  This trial tests whether two cycles of cisplatin or carboplatin with pemetrexed plus the immunotherapies nivolumab and ipilimumab can enable surgery for adults with previously inoperable epithelioid pleural mesothelioma.

  Recruiting Phase 1/2 University Hospital, Antwerp · Edegem, Antwerp · NCT07121374

• Neoadjuvant chemoimmunotherapy and surgery for early-stage cervical cancer

  This study is testing if a new treatment combining chemotherapy and immunotherapy before surgery can help women with early-stage cervical cancer do better and have fewer complications.

  Recruiting at 2 sites Phase 2 Tongji Hospital · Wuhan, Hubei and 1 other locations · NCT06289751

• Neoadjuvant chemotherapy with Camrelizumab for early-stage cervical cancer

  This study is testing if a new combination of chemotherapy and a drug called Camrelizumab can help women with early-stage cervical cancer keep their fertility while aiming for complete remission.

  Recruiting at 2 sites Phase 2 Tongji Hospital · Guangzhou, Guangdong and 1 other locations · NCT06289062

• Comparing neoadjuvant chemoimmunotherapy and concurrent chemoradiotherapy for locally advanced cervical cancer

  This study is testing whether a new treatment combining chemoimmunotherapy and surgery can help people with locally advanced cervical cancer do better than the standard treatment of chemo and radiation.

  Recruiting at 12 sites Phase 2/3 Tongji Hospital · Hefei, Anhui and 11 other locations · NCT06288373

• Neoadjuvant immunochemotherapy for PD-L1-negative locally advanced cervical cancer

  This study is testing a new treatment that combines chemotherapy with a drug called Camrelizumab to see if it can help people with PD-L1-negative locally advanced cervical cancer before surgery.

  Recruiting at 12 sites Phase 2 Tongji Hospital · Hefei, Anhui and 11 other locations · NCT06288360

• Combining Tislelizumab with Chemotherapy for Esophageal Cancer Treatment

  This study is testing if combining a new immune therapy called tislelizumab with chemotherapy can help people with esophageal cancer live longer and stay cancer-free after surgery.

  Recruiting Phase 2 Shanghai Chest Hospital · Shanghai, Shanghai Municipality · NCT06056336

• Neoadjuvant anti-PD-1 plus chemotherapy for esophageal cancer

  This study is testing if combining a new immune therapy with chemotherapy can help people with advanced esophageal cancer do better and live longer.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT05740995

Related topics

Quick answers

How many Neoadjuvant Chemoimmunotherapy clinical trials are recruiting right now?

12, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in China (9 trials), France (2 trials), Italy (2 trials), South Korea (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 5, Phase 1/2: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →